ANGUS Life Sciences expands US biotechnology commercial team

ANGUS Life Sciences fully integrated manufacturer of TRIS AMINO tromethamine buffers, has employed five Regional Account Managers to cover the US biotechnology and pharmaceutical markets.

Mark Henning, ANGUS President and CEO, said: “We believe biotechnology is changing the future of the human condition. As a company, we are dedicated to accelerating advancement of the industry by supplying innovators with the very best production chemicals.

"This, together with providing unmatched levels of product reliability, supply chain transparency and quality assurance, ensures our customers can confidently bring new, life-changing treatments to the people who need them.”

The new Regional Account Managers bring decades of combined industry experience and are playing an essential role in further developing relationships with leading biotechnology and pharmaceutical manufacturers.

Doug Ward, Sales Director at ANGUS Life Sciences, said: “The expansion of our Life Sciences team reflects our dedication to providing customers with the highest quality production chemicals supported by the service and attention they deserve from experts who have a deep and broad understanding of their business.”

The recent appointments to ANGUS Life Sciences’ North American commercial team include the following:

  • Zinab Aldoosi, joining ANGUS from Capsugel
  • Lisa Kelly, previously of Meissner Filtration Products
  • Jay Lachance, comes to ANGUS from Thermo Fisher Scientific
  • Nicholas Null, joining from VWR International
  • Daniel Thomas, previously of Thermo Fisher Scientific.

In addition, ANGUS continues to reinforce its commitment to the global biotechnology and pharmaceutical markets through investments in product development and capacity expansion.

The Company recently completed a project to increase production capacity for high purity TRIS AMINO Ultra Pure at its Sterlington, Louisiana, manufacturing site.

In late 2017, ANGUS also plans to celebrate the opening of a new, state-of-the-art Serinol (2-Amino-1,3-propanediol) manufacturing facility at its existing warehousing and production site in Ibbenbüren, Germany.

You may also like